Buffl

Section VIII. Seizure and Epilepsy

AW
von Angi W.

VIII.10. Which of the following statements is true about women of

childbearing age and antiseizure medication?

a. Lamotrigine carries the highest risk of teratogenicity

b. Folic acid, 0.1 mg daily, is recommended to reduce the risk of teratogenicity in patients who need antiseizure medication

during pregnancy

c. Contraception should be discussed with women of childbear-

ing age when antiseizure medication is prescribed

d. Women with a seizure disorder should stop all antiseizure

medications as soon as they know they are pregnant

e. Dose adjustments of antiseizure medications are not neces-

sary during pregnancy

VIII.10. Answer c.

Contraception should be discussed with all women of

childbearing age when antiseizure medication is pre-

scribed. Oral contraceptives are hepatically metabolized

by the same enzymes as many of the enzyme-inducing

antiseizure medications, so those medications can reduce

the effectiveness of contraception. Folic acid is recom-

mended as a supplement for women with childbearing

potential because supplementation can decrease the rate

of neural tube defects in the growing fetus. A common

dose is 0.4 to 1 mg daily. Although nearly all antiseizure

medications present some risk of teratogenic adverse

effects, valproic acid carries the highest potential harm.

During pregnancy, the dosing of medications may need to

be modified as the patient’s metabolism and volume of

distribution of the medication change. Monitoring drug

levels may be helpful. After delivery, the medications

should be adjusted again to avoid potential adverse effects.

Author

Angi W.

Informationen

Zuletzt geändert